Stockreport

Sana Biotechnology: A Small, Speculative Play [Seeking Alpha]

Sana Biotechnology, Inc.  (SANA) 
PDF Recent single-patient data validate SANA's immune-evasion technology, driving a sharp rally but underscoring early-stage risk and manufacturing challenges. With a $1B [Read more]